期刊文献+

中链脂肪酸-VC复合脂质体制备及初步稳定性 被引量:2

Preparation and Stability of Medium-chain Fatty Acid-VC Complex Liposome
下载PDF
导出
摘要 以磷脂和胆固醇为膜材,脂溶性的中链脂肪酸(MCFAs)和水溶性的VC为模型药物,以脂质体的包封率和粒径为指标,分别采用薄膜法、复乳法、薄膜-高压法、复乳-高压法制备中链脂肪酸-VC复合脂质体,筛选出最佳制备方法(复乳-高压法),并通过单因素试验设计,确定复合脂质体的最优处方工艺为:总脂材质量浓度5.0g/100mL,MCFAs质量浓度10.0mg/mL,VC质量浓度3.0mg/mL,卵磷脂与胆固醇质量比为4:1,卵磷脂质量与无水乙醇体积比为1:10(g/mL),吐温与总脂材质量比为3:10,VE与卵磷脂质量比为4:100,120MPa条件下超微乳化处理2次。制备的复合脂质体MCFAs包封率达到49.01%,VC的包封率达到54.19%,平均粒径90.3nm,在4℃贮藏15d,包封率和粒径变化不大,表明脂质体低温贮藏稳定性良好。 This study was undertaken to prepare medium-chain fatty acid(MCFA)-VC complex liposome using lecithin and cholesterol as membrane materials and optimize the preparation process.Four preparation methods including thin film method,high pressure-thin film method,double emulsification method and high pressure-double emulsification method were compared in terms of entrapment efficiency and liposomal particle size.As a result,high pressure-double emulsification method was found to be the best method.One-facto-at-a-time experiments were carried out to determine the optimal preparation conditions as follows: total lipid material cocentration of 5.0 g/100 mL,MCFAs concentration of 10.0 mg/mL,VC concentration of 3.0 mg/mL,lecithin/absolute ethanol ratio of 1:10(g/mL),mass ratio of lecithin to cholesterol of 4:1,mass ratio of Tween to total lipid material of 3:10,mass ratio of VE to lecithin of 5:1,and twice repeated ultramicroemulsification at 120 MPa,respectively. Under these optimal conditions,the entrapment efficiencies of MCFA and VC were 49.01% and 54.19%,respectively and a mean particle size of 90.3 nm was achieved.The three indexes had little change during storage at 4 ℃ for 15 days,thus indicating excellent stability at low storage temperature.
出处 《食品科学》 EI CAS CSCD 北大核心 2011年第12期106-110,共5页 Food Science
基金 国家重点实验室目标导向项目(SKLF-MB-200808) 国家"863"计划项目(2008AA10Z330)
关键词 中链脂肪酸 VC 脂质体 动态高压微射流 包封率 稳定性 medium-chain fatty acids VC liposome dynamic high pressure microfluidization(DHPM) entrapment efficiency stability
  • 相关文献

参考文献15

  • 1刘成梅,王瑞莲,刘伟,万婕,刘玮琳.中链脂肪酸脂质体的制备及其特性评价[J].食品科学,2007,28(10):143-146. 被引量:10
  • 2许汉林,孙芸,邵继征,熊利容.不同方法制备姜黄素脂质体的研究[J].中国中医药信息杂志,2006,13(7):51-52. 被引量:20
  • 3LIU N,PARK H J.Factors effect on the loading efficiency of vitamin Cloaded chitosan-coated nanoliposomes. Colloids and Surfaces . 2010
  • 4BAI S,GUPTA V,AHSA F.Cationic liposomes as carriers for aerosoliizedformulations of an anionic drug:safety and efficacy study. EuropeanJournal of Pharmaceutical Sciences . 2009
  • 5LIU Chengmei,YANG Shuibing,LIU Wei,et al.Preparation and char-acterization of medium-chain fatty-acid liposomes by lyophilization. Journal of Liposome Research . 2010
  • 6B Marten,MPfeuffer,J Schrezenmeir.Medium-chaintriglycerides. International Dairy Journa . 2006
  • 7Deckbaun RJ,et al.Medium-chain versus long-chain triglyeerid emulsion hydrolysis by lipoprotein lipase and hepatic lipase:implications for the mechanisms of lipase action. Biochemistry . 1990
  • 8KOJI N,TERUYOSHI Y.Medium-chain fatty acids:Functional lipids for the prevention and treatment of the metabolic syndrome. Pharma-cological Research . 2010
  • 9Ma QH,Kuang YZ,Hao XZ,et al.Preparation and charac-terization of tea polyphenols and vitamin E loaded nanoscale complex liposome. Journal of Nanoscience and Nanotechnology . 2009
  • 10SRIAMORNSAK P,THIRAWONG N,NUNTHANID Jet al.Atomic force microscopy imaging of novel self-assembling pectin-liposome nanocomplexes. Carbohydrate Polymers . 2008

二级参考文献13

共引文献28

同被引文献28

  • 1王新春,侯世祥,李文,李小英,周亚伟.白藜芦醇纳米脂质体体外释药和大鼠小肠吸收特性的研究[J].中国中药杂志,2007,32(11):1084-1088. 被引量:26
  • 2Rabesiaka M, Rakotondramasy-Rabesiaka L, Mabille 1, Porte C, Havel J L. Extraction of trans-resveratrol from red wine and optimization by response sudhce methodology [ J ]. Separation and Purification Technology, 2011, 81 (1): 56-61.
  • 3Aziz M lt, Kumar R, Ahmad N. Can,,:er chemoprewmtion by resveratrol: In vitro anct in viwr studies and the underlying mechanisms (Review) [ J]. International journal of oncology, 2003, 23(1):17-28.
  • 4Pandey K B, Rizvi S I. Anti-oxidative action of resveratrol hnplieations for human health [ J ]. Arahian Journal of Chernisty, 2011, 4(3) : 293 -298.
  • 5Ou,H C, Chou F P, Sheen H M, Lin T M, Yang C H, Sheu W H H. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells [ J ]. Clinica Chimica Acta, 2006, 364( 1 ) : 196 -204.
  • 6Pallas M, Gemma C, Smith M A, Coto-Montes A, Pelegri C, Vilaplana J, Camins A. Resveratrol and neurodegenerative disease: activation of SIRT1 as the potential pathway towards neuroprotection [ J]. Current Neurovascular Research, 2009, 6( 1 ) : 70 - 81.
  • 7Kim S, Ng W K, Dong Y, Das S, Tan R B H. Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisoIvent precipitation[ J]. Journal of Food Engineering, 2012, 108(1 ) :37 -42.
  • 8Mozafari M R. Nanoliposomes: Preparation and Analysis [ J]. Liposomes, Methods in Molecular Biology, 2010, 605: 29- 48.
  • 9Gharib A, Faezizadeh Z, Godarzee M. Therapeutic efficacy of epigallocatechin gallate-loaded nanoliposomes against burn wound infection by methicillin-resistant staphylococcus aureus [ J ]. Skin Pharmacology Physiology, 2013, 26 ( 2 ) : 68 - 75.
  • 10Fan M, Xu S, Xia S, Zhang X. Preparation of salidroside nano- liposomes by ethanol injection method and in vitro release study[ J]. European Food Research and Technology, 2008, 227 ( 1 ) : 167 - 174.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部